Welcome to our dedicated page for CHTH SEC filings (Ticker: CHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CNL Healthcare Properties, Inc. filings document the company’s material-event reports, audited consolidated financial statements, stockholder voting matters, governance actions, and common-stock registration status. The filing record includes 8-K disclosures covering financial statements, annual-meeting results, material agreements, capital-structure matters, risk-factor categories, and other corporate events.
The company’s Form 15-12G records the termination of registration for its common stock under Exchange Act Section 12(g) and the suspension of Exchange Act reporting duties after the completed merger sequence in which CNL Healthcare Properties’ separate corporate existence ceased and SSL Sparti Property Holdings Inc. became successor by merger.
Sonida Senior Living, Inc. (SNDA) is proposing to acquire CNL Healthcare Properties, Inc. (CHP) in a cash-and-stock deal valued at $6.90 per CHP share. Each share of CHP common stock will be converted into $2.32 in cash plus SNDA stock worth $4.58, based on the 10-day volume-weighted average SNDA price before closing, with a collar so each CHP share receives between 0.1318 and 0.2015 SNDA shares.
SNDA will also raise approximately $110 million through a private placement of 4,113,688 SNDA shares to Conversant Capital affiliates and Silk Partners at $26.74 per share to help fund the cash portion. After the transaction and this financing, existing SNDA holders (including these investors) are expected to own about 39.5%–50% of SNDA on a fully diluted basis, while former CHP stockholders will hold about 50%–60.5%, depending on SNDA’s trading price.
SNDA stockholders are being asked to approve an increase in authorized common shares from 30 million to 100 million, the issuance of SNDA shares to CHP holders and the new investors, and certain charter changes. CHP stockholders are being asked to approve the merger, elect directors, ratify the auditor, and allow potential adjournments. Large SNDA holder Conversant, controlling about 52.6% of SNDA voting power, has agreed to vote in favor of key SNDA proposals, effectively ensuring their approval.
CNL Healthcare Properties (CHTH) filed its Q3 2025 report, showing steady operating momentum and a narrower loss. Total revenues were $99.294 million for the quarter, up from $92.797 million a year ago, as resident fees and services rose with higher occupancy and rate increases. Net loss attributable to common stockholders improved to $1.578 million versus $3.174 million. Quarterly NOI was $28.318 million, up from $25.938 million.
The balance sheet showed $1.302 billion in total assets and $693.609 million in stockholders’ equity. Liquidity was approximately $92.7 million as of September 30, 2025, including $57.7 million cash and $35.0 million available on the revolver. The company had $565.0 million outstanding under its 2023 credit facilities maturing in May 2026 and reported compliance with all covenants.
Operationally, 13 triple-net leases were renewed in May 2025 to May 2030, supporting rental income, with future minimum lease payments totaling $154.020 million. Year‑to‑date cash flows from operating activities were $43.892 million, funding $13.359 million in cash distributions.
Subsequent event: On November 4, 2025, CNL agreed to be acquired by Sonida Senior Living in a cash-and-stock transaction valued at approximately $1.80 billion, with each CNL share to receive Sonida stock per an exchange ratio and $2.32 in cash, subject to customary approvals and conditions.
CNL Healthcare Properties entered a Merger Agreement to be acquired by Sonida Senior Living in a stock-and-cash deal. Each CNL share will receive $2.32 in cash plus Parent common stock based on an exchange ratio equal to $4.58 divided by the Closing VWAP, with an asymmetrical collar: if the Closing VWAP is below $22.73, the ratio is 0.2015; if above $34.76, the ratio is 0.1318.
The deal requires approvals from both companies’ stockholders, regulatory clearances, NYSE listing of new Parent shares, and an effective Form S-4. Closing is anticipated in Q2 2026. Either side may owe a $30 million termination fee in specified circumstances; CNL may reimburse up to $10 million of Parent expenses if its stockholder approval is not obtained. Affiliates of Conversant agreed to support Parent approvals and to purchase $110 million of Parent stock at closing. CNL also adopted a bylaw amendment designating Maryland courts as the exclusive forum for specified internal corporate claims.